Orchestra BioMed Holdings, Inc.·4

Jan 2, 6:55 PM ET

Taylor Andrew Lawrence 4

4 · Orchestra BioMed Holdings, Inc. · Filed Jan 2, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.0001 per share

    2026-01-02$4.31/sh3,452$14,878451,493 total
Footnotes (1)
  • [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Documents

1 file
  • 4
    tm261746-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT